SAFETY AND EFFICACY OF SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY

被引：0
|
作者：
Coffin, Carla
Lim, Young-Suk
Bae, Ho
Heo, Jeong
Hui, Aric J.
Chen, Chien-Hung
Flaherty, John F.
Gaggar, Anuj
Mo, Shuyuan
Hahambis, Thomas A.
Jump, Belinda
Trinh, Huy N.
Tsang, Owen
Janssen, Harry L.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1525
引用
收藏
页码：S1320 / S1321
页数：2
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY OF SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY
    Lim, Young-Suk
    Lampertico, Pietro
    Bae, Ho S.
    Chuang, Wan Long
    Heo, Jeong
    Huang, Yi-Hsiang
    Hui, Aric Josun
    Lin, Chun-Yen
    Fournier, Claire
    Flaherty, John F.
    Gaggar, Anuj
    Lau, Audrey H.
    Mo, Shuyuan
    Suri, Vithika
    Subramanian, Mani
    Trinh, Huy N.
    Tsang, Owen
    Ryder, Stephen D.
    Janssen, Harry L. A.
    Chen, Chien Hung
    [J]. HEPATOLOGY, 2019, 70 : 316A - 317A
  • [2] EFFICACY AND SAFETY OF SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH RENAL IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY
    Janssen, Harry L. A.
    Lim, Young-Suk
    Gane, Edward J.
    Fournier, Claire
    Ahn, Sang Hoon
    Tsang, Owen
    Chuang, Wan Long
    Heo, Jeong
    Hui, Aric Josun
    Elkhashab, Magdy
    Chen, Chi-Yi
    Su, Wei-Wen
    Flaherty, John F.
    Gaggar, Anuj
    Tan, Susanna
    Lau, Audrey H.
    Suri, Vithika
    Mo, Shuyuan
    Subramanian, Mani
    Jafri, Syed-Mohammed
    Agarwal, Kosh
    Lampertico, Pietro
    Marchesini, Giulo
    Coffin, Carla S.
    Huang, Yi-Hsiang
    [J]. HEPATOLOGY, 2019, 70 : 306A - 307A
  • [3] Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Hepatic Impairment: Week 48 Results From a Phase 2 Open Label Study
    Bae, Ho S.
    Lim, Young-Suk
    Trinh, Huy
    Heo, Jeong
    Chuang, Wan-Long
    Hui, Aric Josun
    Elkhashab, Magdy
    Tan, Susanna K.
    Mo, Shuyuan
    Guion, Matthew
    Jump, Belinda
    Flaherty, John
    Suri, Vithika
    Gaggar, Anuj
    Tsang, Tak Yin Owen
    Andreone, Pietro
    Janssen, Harry
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S567 - S567
  • [4] Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with hepatic impairment: week 48 results from a phase 2 open label study
    Lim, Young-Suk
    Lin, Chun-Yen
    Heo, Jeong
    Bae, Ho
    Chuang, Wan-Long
    Hui, Aric Josun
    Elkhashab, Magdy
    Trinh, Huy
    Tan, Susanna
    Mo, Shuyuan
    Flaherty, John F.
    Suri, Vithika
    Gaggar, Anuj
    Subramanian, Mani
    Tsang, Tak Yin Owen
    Ryder, Stephen
    Andreone, Pietro
    Janssen, Harry
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S872 - S872
  • [5] Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study
    Janssen, Harry
    Heo, Jeong
    Fournier, Claire
    Ahn, Sang Hoon
    Coffin, Carla S.
    Hui, Aric Josun
    Elkhashab, Magdy
    Jafri, Syed-Mohammed
    Mo, Shuyuan
    Winans, Jake
    Flaherty, John
    Gaggar, Anuj
    Chuang, Wan-Long
    Gane, Ed J.
    Lim, Young-Suk
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S530 - S530
  • [6] Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with renal impairment: week 48 results from a phase 2 open label study
    Janssen, Harry
    Lampertico, Pietro
    Chen, Chi-Yi
    Heo, Jeong
    Fournier, Claire
    Ahn, Sang Hoon
    Tsang, Tak Yin Owen
    Coffin, Carla
    Reggiani, Giulio Marchesini
    Huang, Yi-Hsiang
    Hui, Aric Josun
    Elkhashab, Magdy
    Chen, Chien-Hung
    Jafri, Syed Mohammed Raza
    Tan, Susanna
    Mo, Shuyuan
    Suri, Vithika
    Flaherty, John F.
    Gaggar, Anuj
    Subramanian, Mani
    Agarwal, Kosh
    Chuang, Wan-Long
    Gane, Edward
    Lim, Young-Suk
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S866 - S867
  • [7] EFFICACY AND SAFETY OF SWITCHING TO TENOFOVIR ALAFENAMIDE IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B PATIENTS WITH RENAL IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY
    Bae, Ho
    Trinh, Huy N.
    Janssen, Harry L.
    Fournier, Claire
    Chuang, Wan-Long
    Heo, Jeong
    Chen, Chi-Yi
    Flaherty, John F.
    Gaggar, Anuj
    Tan, Susanna
    Mo, Shuyuan
    Naik, Sarjita
    Yee, Leland
    Jafri, Syed-Mohammed
    Lampertico, Pietro
    Coffin, Carla
    Lim, Young-Suk
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1319 - S1320
  • [8] Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study
    Lim, Young-Suk
    Lin, Chun-yen
    Heo, Jeong
    Bae, Ho
    Chuang, Wan-Long
    Tsang, Tak Yin Owen
    Fournier, Claire
    Hui, Aric Josun
    Huy Trinh
    Tan, Susanna
    Zhao, Yang
    Flaherty, John F.
    Suri, Vithika
    Gaggar, Anuj
    Brainard, Diana
    Ryder, Stephen
    Janssen, Harry L. A.
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S755 - S756
  • [9] Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study
    Janssen, Harry L. A.
    Lim, Young-Suk
    Lampertico, Pietro
    Heo, Jeong
    Chen, Chi-Yi
    Fournier, Claire
    Tsang, Tak Yin Owen
    Bae, Ho
    Chen, Chien-Hung
    Coffin, Carla S.
    Ahn, Sang Hoon
    Trinh, Huy
    Flaherty, John F.
    Abramov, Frida
    Zhao, Yang
    Liu, Yang
    Lau, Audrey
    German, Polina
    Chuang, Wan-Long
    Agarwal, Kosh
    Gane, Edward
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (08): : 718 - 733
  • [10] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) AND/OR OTHER ORAL ANTIVIRALS (OAVS) TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: FINAL 2-YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 2
    Lim, Young-Suk
    Lin, Chun-Yen
    Heo, Jeong
    Bae, Ho
    Chuang, Wan-Long
    Yin, Tak
    Tsang, Owen
    Fournier, Claire
    Hui, Aric Josun
    Trinh, Huy
    Chan, Carol Yee Kwan
    Tan, Susanna K.
    Zhao, Yang
    Flaherty, John F.
    Suri, Vithika
    Gaggar, Anuj
    Brainard, Dianna M.
    Ryder, Stephen
    La Janssen, Harry
    [J]. GUT, 2021, 70 : A77 - A77
12345